J. B. Vermorken

Impact of Adjuvant Chemotherapy and Surgical Staging in Early-Stage Ovarian Carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm Trial

J. Baptist Trimbos, Ignace Vergote, Giorgio Bolis et al. · JNCI Journal of the National Cancer Institute · 2003 · 679 citations · Full text

Predictors of response to subsequent chemotherapy in platinum pretreated ovarian cancer: A multivariate analysis of 704 patients

E. A. Eisenhauer, J. B. Vermorken, M. van Glabbeke · Annals of Oncology · 1997 · 281 citations

Multivariate Analysis, Medicine, Subsequent Chemotherapy +8

Docetaxel (TaxotereTM) in advanced gastric cancer: results of a phase II clinical trial. EORTC Early Clinical Trials Group

Aarón Sulkes, Joan A. Smyth, C. Sessa et al. · British Journal of Cancer · 1994 · 220 citations

Gastrointestinal Oncology, Advanced Gastric Cancer, Medicine +9

Advanced epithelial ovarian cancer: 1993 consensus statements

Darlene Allen, J. Baak, D Belpomme et al. · Annals of Oncology · 1993 · 185 citations · Full text

Gynecological Surgery, Medicine, Gynecology +4

Preclinical in vivo activity of 2',2'-difluorodeoxycytidine (Gemcitabine) against human head and neck cancer.

B.J.M. Braakhuis, Guus A.M.S. van Dongen, J. B. Vermorken et al. · Data Archiving and Networked Services (DANS) · 1991 · 136 citations

Neck Cancer, Chemoprevention Strategy, Pathology +18